Amgen Inc (AMGN)
262.75
-1.32
(-0.50%)
USD |
NASDAQ |
Apr 18, 16:00
262.75
0.00 (0.00%)
After-Hours: 20:00
Amgen Cash from Investing (TTM): -26.20B for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -26.20B |
September 30, 2023 | -2.588B |
June 30, 2023 | -2.593B |
March 31, 2023 | -4.575B |
December 31, 2022 | -6.044B |
September 30, 2022 | -2.801B |
June 30, 2022 | -2.461B |
March 31, 2022 | 941.00M |
December 31, 2021 | 733.00M |
September 30, 2021 | -421.00M |
June 30, 2021 | -2.122B |
March 31, 2021 | -5.49B |
December 31, 2020 | -5.401B |
September 30, 2020 | -9.98B |
June 30, 2020 | -2.98B |
March 31, 2020 | 1.924B |
December 31, 2019 | 5.709B |
September 30, 2019 | 7.035B |
June 30, 2019 | 2.795B |
March 31, 2019 | 2.988B |
December 31, 2018 | 14.34B |
September 30, 2018 | 18.90B |
June 30, 2018 | 15.79B |
March 31, 2018 | 11.04B |
December 31, 2017 | -4.024B |
Date | Value |
---|---|
September 30, 2017 | -5.168B |
June 30, 2017 | -5.581B |
March 31, 2017 | -4.425B |
December 31, 2016 | -8.658B |
September 30, 2016 | -7.669B |
June 30, 2016 | -7.283B |
March 31, 2016 | -8.985B |
December 31, 2015 | -5.547B |
September 30, 2015 | -4.94B |
June 30, 2015 | -5.84B |
March 31, 2015 | -5.939B |
December 31, 2014 | -5.752B |
September 30, 2014 | -16.24B |
June 30, 2014 | -15.46B |
March 31, 2014 | -11.04B |
December 31, 2013 | -8.469B |
September 30, 2013 | -382.00M |
June 30, 2013 | -1.436B |
March 31, 2013 | -5.835B |
December 31, 2012 | -9.99B |
September 30, 2012 | -8.179B |
June 30, 2012 | -5.863B |
March 31, 2012 | -2.577B |
December 31, 2011 | -786.00M |
September 30, 2011 | -1.057B |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-26.20B
Minimum
Dec 2023
7.035B
Maximum
Sep 2019
-2.870B
Average
-2.588B
Median
Sep 2023
Cash from Investing (TTM) Benchmarks
Gilead Sciences Inc | -2.265B |
Johnson & Johnson | 878.00M |
Eli Lilly and Co | -7.153B |
Merck & Co Inc | -14.08B |
Vertex Pharmaceuticals Inc | -3.142B |